Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Skin Neoplasms 1Rectal Diseases 1Neoplasms 1Hemorrhage 1Endometriosis 1Dysplastic Nevus Syndrome 1Diverticulitis 1Crohn Disease 1Constipation 1Colonic Diseases 1Colitis, Ulcerative 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms × Sutures × Clear all
NCT00107627 2009-06-25

Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery

Queensland Centre for Gynaecological Cancer

Phase 3 Completed
90 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡